Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

M-PEG-TA由甲氧基聚乙二醇和硫辛酸通过化学反应连接而成。Methoxy PEG作为一种亲水性的聚合物链，具有多个反应活性位点，可以与硫辛酸分子进行化学连接。在反应过程中，Methoxy PEG的末端官能团可能与硫辛酸中的特定官能团发生反应，形成稳定的化学键连接。

SciSparc Ltd (NASDAQ:SPRC) shares are ripping higher Monday after the company announced that its collaboration with Clearmind ...

Clearmind Medicine (CMND) has signed a non-binding Letter of Intent with Polyrizon (PLRZ) to develop a novel intranasal formulation for its ...

Aiming to improve bioavailability and optimize the therapeutic effect of Clearmind’s psychedelic-based treatmentsVancouver, Canada, March 19, ...

This assay was used to guide the fractionation of this extract and allowed the isolation of four compounds: the new naphthoquinone eleutherinone[8-methoxy-1-methyl-1,3-dihydro-naphtho(2,3-c)furan-4,9 ...

1.结构：MPEG-BSA是由甲氧基聚乙二醇（MPEG）和牛血清白蛋白（BSA）结合而成的复合物。MPEG部分赋予其优良的亲水性和生物相容性，而BSA部分则提供生物活性。 2.特性：MPEG-BSA复合物具有较高的稳定性，能够在不同的环境条件下保持其结构和功能的完整性。 细胞 ...

Aiming to improve bioavailability and optimize the therapeutic effect of Clearmind's psychedelic-based treatments Vancouver, Canada, March 19, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: ...

Eleusis' drug will slot into Beckley's pipeline alongside lead drug BPL-003, an intranasal formulation of psychoactive compound 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) heading for phase 2 ...

The patent is based on preclinical trial results led by Professor Gal Yadid and his team at the Gonda Multidisciplinary Brain ...

After hours: March 17 at 4:05:02 PM EDT Loading Chart for GHRS ...